Quarterly report pursuant to Section 13 or 15(d)

Revenues (Tables)

v3.20.1
Revenues (Tables)
3 Months Ended
Mar. 31, 2020
Revenues  
Schedule of revenues disaggregated by category

Revenues disaggregated by category were as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended 

 

 

 

 

March 31, 

 

 

 

 

2020

    

2019

 

 

Product sales:

 

 

 

 

 

 

 

 

Gross product sales

 

$

15,371

 

$

9,916

 

 

Discounts and allowances

 

 

(2,691)

 

 

(1,862)

 

 

Product sales, net

 

$

12,680

 

$

8,054

 

 

 

 

 

 

 

 

 

 

 

Revenues from collaborations:

 

 

 

 

 

 

 

 

License revenues

 

 

39,858

 

 

4,499

 

 

Research and development services and others

 

 

3,223

 

 

71

 

 

Total revenues from collaborations

 

 

43,081

 

 

4,570

 

 

Total revenues

 

$

55,761

 

$

12,624

 

 

 

Schedule of revenues from product sales disaggregated by customers

The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended 

 

 

 

 

March 31, 

 

 

 

 

2020

    

2019

 

 

Grifols

 

 

77%

 

 

36%

 

 

ASD Healthcare and Oncology Supply

 

 

12%

 

 

33%

 

 

McKesson Specialty Care Distribution Corporation

 

 

9%

 

 

24%

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of product revenue allowance and reserve categories

The following table summarizes activity in each of the product revenue allowance and reserve categories for the three months ended March 31, 2020 and 2019 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chargebacks,

 

Government

 

 

 

 

 

 

Discounts and

 

and Other

 

 

 

 

 

 

Fees

 

Rebates

 

Returns

 

Total

Balance at January 1, 2020

    

$

1,293

 

$

1,801

 

$

238

 

$

3,332

Provision related to current period sales

 

 

1,487

 

 

745

 

 

 —

 

 

2,232

Credit or payments made during the period

 

 

(1,324)

 

 

(627)

 

 

(58)

 

 

(2,009)

Balance at March 31, 2020

 

$

1,456

 

$

1,919

 

$

180

 

$

3,555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chargebacks,

 

Government

 

 

 

 

 

 

 

 

Discounts and

 

and Other

 

 

 

 

 

 

 

 

Fees

 

Rebates

 

Returns

 

Total

Balance at January 1, 2019

    

$

622

 

$

843

 

$

170

 

$

1,635

Provision related to current period sales

 

 

855

 

 

706

 

 

99

 

 

1,660

Credit or payments made during the period

 

 

(735)

 

 

(323)

 

 

 —

 

 

(1,058)

Balance at March 31, 2019

 

$

742

 

$

1,226

 

$

269

 

$

2,237